Aiarpi A Ezdoglian
Overview
Explore the profile of Aiarpi A Ezdoglian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borozdenko D, Gonchar D, Bogorodova V, Tarasenko D, Kramarova E, Khovanova S, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38068887
This study investigates the therapeutic potential of a new compound, potassium 2-[2-(2-oxo-4-phenylpyrrolidin-1-yl) acetamido]ethanesulfonate (Compound ), in depression. Willner's chronic unpredictable mild stress model of male Wistar rats was used as...
2.
Kramarova E, Borisevich S, Khamitov E, Korlyukov A, Dorovatovskii P, Shagina A, et al.
Molecules
. 2022 Nov;
27(21).
PMID: 36364369
The synthesis of the products of the 1,3-propanesultone ring opening during its interaction with amides of pyridinecarboxylic acids has been carried out. The dependence of the yield of the reaction...
3.
Borozdenko D, Shmigol T, Ezdoglian A, Gonchar D, Karpechenko N, Lyakhmun D, et al.
Molecules
. 2022 Sep;
27(17).
PMID: 36080256
Ischemic stroke triggers a whole cascade of pathological changes in the brain, one of which is postischemic inflammation. Since in such cases thrombolytic therapy is often not possible, methods that...
4.
Borozdenko D, Ezdoglian A, Shmigol T, Gonchar D, Lyakhmun D, Tarasenko D, et al.
Molecules
. 2021 Oct;
26(20).
PMID: 34684709
We performed an in silico, in vitro, and in vivo assessment of a potassium 2-[2-(2-oxo-4-phenylpyrrolidin-1-yl) acetamido]ethanesulfonate (compound ) as a potential prodrug for cognitive function improvement in ischemic brain injury....